Lobbying Activity Report

728-31000

Organization: Canadian Diabetes Association operating as Diabetes Canada
Associated registration: 6886-728-50
Lobbying Activity date: 2023-11-27
Arranged a meeting: No
Posted date: 2023-12-13

In-house lobbyists who participated in the lobbying activity: Joan King
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Pharmaceutical, Laboratory & Blood Services Division, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement, Health

Mariana Diacu, Excutive Director
Laboratory & Blood Services, Provincial Health Services Authority

Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Luba Kamenko, Director
Pharmaceutical, Laboratory & Blood Services, Health

Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health

Derek Tryan, A/Exective Director
Pharmaceutical, Laboratory & Blood Services, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Diabetes Canada recommends the government of British Columbia enhance access to diabetes medications, devices and supplies, and supports for British Columbians living with diabetes.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
Diabetes Canada recommends the government of British Columbia expand patient choice of medications, devices and supplies because managing diabetes cannot be managed with a one-size-fits-all approach.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
Diabetes Canada recommends the government of British Columbia reduce the administrative and other barriers to access so British Columbians living with diabetes can readily access the medication, devices and supplies they need to manage their diabetes.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
 
Senior officer who filed this Lobbying Activity Report: Laura Syron
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: